Details of the Drug

General Information of Drug (ID: DM67AMC)

Drug Name

GSK2654909A

Indication

Disease Entry	ICD 11	Status	REF
Virus infection	1A24-1D9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01659086) Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of Age. U.S. National Institutes of Health.